User profiles for M. Merker

Matthias Merker

Research Center Borstel
Verified email at fz-borstel.de
Cited by 5269

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

…, P van Helden, S Niemann, M Merker… - The lancet Respiratory …, 2017 - thelancet.com
Global tuberculosis incidence has declined marginally over the past decade, and tuberculosis
remains out of control in several parts of the world including Africa and Asia. Although …

Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement

…, AM Mandalakas, FP Maurer, M Merker… - The Lancet Infectious …, 2023 - thelancet.com
Drug-resistant tuberculosis is a substantial health-care concern worldwide. Despite culture-based
methods being considered the gold standard for drug susceptibility testing, molecular …

Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage

M Merker, C Blin, S Mona, N Duforet-Frebourg… - Nature …, 2015 - nature.com
M. tuberculosis and the other members of the M. tuberculosis complex (MTBC) remain the
leading bacterial killers worldwide and still account for 1.3 million deaths annually 1 . Of major …

[HTML][HTML] Perspective for precision medicine for tuberculosis

…, T Nishiguchi, A Mandalakas, M Merker… - Frontiers in …, 2020 - frontiersin.org
… Immunological assays could improve outcomes in populations in whom diagnosis is very
difficult, such as children in whom reports of the T-cell activation marker (TAM-TB) test suggest …

[HTML][HTML] The 2021 WHO catalogue of Mycobacterium tuberculosis complex mutations associated with drug resistance: a genotypic analysis

…, M Mihalic, M WILCOX, M ZIGNOL, M Merker… - The Lancet …, 2022 - thelancet.com
Background Molecular diagnostics are considered the most promising route to achievement
of rapid, universal drug susceptibility testing for Mycobacterium tuberculosis complex (MTBC…

Whole-genome-based Mycobacterium tuberculosis surveillance: a standardized, portable, and expandable approach

…, J Rothgänger, KM Walter, M Merker… - Journal of clinical …, 2014 - Am Soc Microbiol
… Such large SNP differences among isolates with identical IS6110 patterns in a low-incidence
setting is rather unexpected, as this has been considered a reliable marker for isolates …

Detection of drug-resistant tuberculosis by Xpert MTB/RIF in Swaziland

E Sanchez-Padilla, M Merker, P Beckert… - … England Journal of …, 2015 - Mass Medical Soc
Rapid diagnosis of drug-resistant tuberculosis is important in determining proper
management. This letter reports on limitations of the Xpert MTB/RIF assay in determining …

[HTML][HTML] A cluster of multidrug-resistant Mycobacterium tuberculosis among patients arriving in Europe from the Horn of Africa: a molecular epidemiological study

TM Walker, M Merker, AM Knoblauch… - The Lancet Infectious …, 2018 - thelancet.com
Background The risk of tuberculosis outbreaks among people fleeing hardship for refuge in
Europe is heightened. We describe the cross-border European response to an outbreak of …

Effect of basicity on persulfate reactivity

OS Furman, AL Teel, M Ahmad, MC Merker… - Journal of …, 2011 - ascelibrary.org
… Solutions of 0.025, 0.05, 0.25, and 0.5 M persulfate were prepared containing one of the
probe compounds; each solution was adjusted to pH 12 using 5 M NaOH. All reactions were …

Association of baseline inflammation with effectiveness of nutritional support among patients with disease-related malnutrition: a secondary analysis of a randomized …

M Merker, M Felder, L Gueissaz, R Bolliger… - JAMA network …, 2020 - jamanetwork.com
… As a sensitivity analysis, we also included CRP as a continuous marker in the model.
Finally, we performed a subgroup analysis limiting data to patients with a main diagnosis of …